By: Benzinga
Afternoon Market Losers
Synta Pharmaceuticals (NASDAQ: SNTA ) is down 32.32% to $4.99 after Synta reported positive overall survival results from GALAXY-1 Phase 2b/3 trial of Ganetespib in second-line non-small cell lung cancer. Infinity Pharmaceuticals (NASDAQ: INFI ) dropped 26.10% to 19.92 on Phase 1 data. Affymax (NASDAQ: AFFY ) dropped 19.23%
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here